Torres S M, McKeever P J, Johnston S D
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul 55108.
Am J Vet Res. 1991 Mar;52(3):416-21.
To determine the effect of oral administration of prednisolone on thyroid function, 12 healthy Beagles were given 1.1 mg of prednisolone/kg of body weight every 12 hours for 22 days after 8 days of diagnostic testing of the dogs before treatment with prednisolone. Thyroid-stimulating hormone (TSH) and thyrotropin-releasing hormone (TRH) response tests were performed before treatment (days 1 and 8 of the study) and during treatment (days 21 and 28 of the study). Blood samples were collected daily at 8 AM and 2 and 8 PM to rule out normal daily hormone fluctuations as the cause of a potential decrease in serum triiodothyronine (T3), thyroxine (T4), and free T4 (fT4) concentrations. Serum T3, T4, and fT4 concentrations before treatment and 1 day and 21 days after the first prednisolone dose were compared by analyses of variance. Post-TSH and -TRH serum T3 and T4 concentrations before and during treatment were compared, using the Student t test for paired data. Oral administration of prednisolone significantly (P less than 0.005) decreased serum T3, T4, and fT4 concentrations in the 8 AM and 2 and 8 PM samples obtained 1 day and 21 days after the first prednisolone dose. Serum T4 and fT4 concentrations in 8 AM and 2 PM samples were significantly (P less than 0.05) lower 21 days after the first prednisolone dose than they were at 1 day after the first dose. Before treatment, serum T4 concentration in the 2 PM samples was significantly (P less than 0.05) higher than serum T4 concentration in 8 AM and 8 PM samples.(ABSTRACT TRUNCATED AT 250 WORDS)
为确定口服泼尼松龙对甲状腺功能的影响,在对12只健康比格犬进行泼尼松龙治疗前8天的诊断测试后,每12小时给它们口服1.1毫克/千克体重的泼尼松龙,持续22天。在治疗前(研究的第1天和第8天)以及治疗期间(研究的第21天和第28天)进行促甲状腺激素(TSH)和促甲状腺激素释放激素(TRH)反应测试。每天上午8点、下午2点和8点采集血样,以排除正常的每日激素波动是血清三碘甲状腺原氨酸(T3)、甲状腺素(T4)和游离T4(fT4)浓度潜在下降的原因。通过方差分析比较治疗前以及首次服用泼尼松龙剂量后1天和21天的血清T3、T4和fT4浓度。使用配对数据的Student t检验比较治疗前和治疗期间TSH和TRH后血清T3和T4浓度。口服泼尼松龙显著(P小于0.005)降低了首次服用泼尼松龙剂量后1天和21天上午8点、下午2点和8点采集样本中的血清T3、T4和fT4浓度。首次服用泼尼松龙剂量21天后上午8点和下午2点样本中的血清T4和fT4浓度显著(P小于0.05)低于首次服药后1天的浓度。治疗前,下午2点样本中的血清T4浓度显著(P小于0.05)高于上午8点和晚上8点样本中的血清T4浓度。(摘要截短至250字)